BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37971637)

  • 21. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
    Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
    Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robot-assisted supine extraperitoneal retroperitoneal lymph node dissection: a novel approach for template dissection in post-chemotherapy residual mass in non-seminomatous germ cell tumours.
    Pooleri GK; Bijalwan P; Kesavan R; Philip A; Keechilat P
    J Robot Surg; 2019 Feb; 13(1):171-173. PubMed ID: 29728822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort.
    Taylor J; Becher E; Wysock JS; Lenis AT; Litwin MS; Jipp J; Langenstroer P; Johnson S; Bjurlin MA; Tan HJ; Lane BR; Huang WC
    Eur Urol Focus; 2021 Nov; 7(6):1403-1408. PubMed ID: 32682794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robot-assisted retroperitoneal lymph node dissection: Initial experience in Japan.
    Takahara K; Motonaga T; Okumura J; Yamakawa S; Yagi K; Nakamura W; Saruta M; Nukaya T; Takenaka M; Zennami K; Ichino M; Sasaki H; Sumitomo M; Shiroki R
    Asian J Endosc Surg; 2024 Jan; 17(1):e13262. PubMed ID: 37944943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
    Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
    World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience.
    Kamel MH; Littlejohn N; Cox M; Eltahawy EA; Davis R
    J Endourol; 2016 May; 30(5):510-9. PubMed ID: 26669219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robotic retroperitoneal lymphadenectomy in paratesticular rhabdomyosarcoma.
    Quiroz YY; Moncada E; Llorens E; Schwartzmann I; Caffarati J; Bujons A
    J Pediatr Urol; 2022 Jun; 18(3):401-403. PubMed ID: 35410803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
    Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
    World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy.
    Nicolai N; Nazzani S; Tesone A; Macchi A; Piva L; Salvioni R; Stagni S; Torelli T; Agostini E; Celso F; Giannatempo P; Procopio G; Avuzzi B; Lanocita R; Cattaneo L; Catanzaro M; Biasoni D
    Tumori; 2023 Aug; 109(4):379-386. PubMed ID: 35915559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor.
    Mistretta FA; de Cobelli O; Verze P; Botticelli F; Jannello L; Luzzago S; Cozzi G; Bianchi R; Di Trapani E; Ferro M; Cordima G; Bottero D; Matei DV; Mirone V; Musi G
    Asian J Androl; 2022; 24(6):579-583. PubMed ID: 35381697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 34. Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours.
    Ohlmann CH; Saar M; Pierchalla LC; Zangana M; Bonaventura A; Stöckle M; Siemer S; Heinzelbecker J
    Sci Rep; 2021 May; 11(1):10700. PubMed ID: 34021196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes.
    Garg H; Mansour AM; Psutka SP; Kim SP; Porter J; Gaspard CS; Dursun F; Pruthi DK; Wang H; Kaushik D
    BJU Int; 2023 Jul; 132(1):9-30. PubMed ID: 36754376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
    Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
    World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.